Multi-omics dissection of fatty acid metabolism heterogeneity identifies PRDX1 as a prognostic marker in bladder cancer. Wang L, Chang Z, Chen SY, Yang JW, et al. Front Immunol 2025;16:1669822.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wang L, Chang Z, Chen SY, Yang JW, et al. Multi-omics dissection of fatty acid metabolism heterogeneity identifies PRDX1 as a prognostic marker in bladder cancer. Front Immunol 2025;16:1669822.
PMID: 41019038